| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―07 |
Проспективный анализ приверженности длительной фармакотерапии сердечно-сосудистых заболеваний среди пациентов, переболевших COVID-19 |
А.Р. Тяпаева, О.Н. Семенова, Е.А. Наумова |
| 2 |
[GO] |
2024―Nov―19 |
Артериальная гипертензия и коронавирусная инфекция COVID-19 |
Ливенцева М.М., Черняк С.В., Нечесова Т.А., Казак Л.Г., Матусевич И.Д., Павлова О.С. |
| 3 |
[GO] |
2024―Jul―11 |
Comparative Analysis of the Clinical Course of COVID-19 Associated with Cardiovascular Syndrome |
Х.А. Акилов, Р.Р. Ибадов, С.Х. Ибрагимов |
| 4 |
[GO] |
2024―May―17 |
Features of the Clinical Course of Chronic Coronary Heart Disease after COVID-19 Infection |
О.А. Суджаева, И.С. Карпова, О.В. Кошлатая, М.Г. Колядко, И.И. Русских, И.Д. Козлов, Е.А. Ванкович |
| 5 |
[GO] |
2023―Nov―09 |
Assessment of the Prevalence of Cardiovascular Events and Factors that Increase Cardiovascular Risk in Patients with COVID-19 |
У.К. Камилова, Д.Р. Машарипова, Н.А. Нуритдинов, Б.Б. Утемурадов, Д.Р. Тагаева, Е.Б. Петрова, et al. (+3) А.А. Плешко, Е.А. Григоренко, Н.П. Митьковская |
| 6 |
[GO] |
2023―Jan―18 |
Comparative Characteristics of Drug Therapy in Patients with Coronavirus Infection against Cardiovascular Disease in Clinical Practice of City Polyclinics and Infectious In-Patient Department |
Тяпаева, А.Р., Наумова, Е.А., Семенова, О.Н., et al. (+2) Булаева, Ю.В. |
| 7 |
[GO] |
2022―Sep―26 |
COVID-19 and Pulmonary Embolism |
А.А. Плешко |
| 8 |
[GO] |
2022―Sep―26 |
Features of Chronic Ischemic Heart Disease after COVID-19: Preliminary Results |
И.С. Карпова, О.А. Суджаева, О.В. Кошлатая, И.Д. Козлов, Т.В. Ильина, Е.А. Ванькович, М.Г. Колядко |
| 9 |
[GO] |
2022―Sep―26 |
Certain Features of Inflammation and Endothelial Dysfunction in Persons with Confirmed New Coronavirus Infection SARS-CoV-2 and Acute Coronary Artery Thrombosis |
А.А. Плешко, М.Г. Колядко, И.И. Русских, Е.А. Григоренко, Н.П. Митьковская |
| 10 |
[GO] |
2022―Aug―16 |
Treatment of Arrhythmias in the Context of the COVID-19 Pandemic |
Л.В. Якубова, В.А. Снежицкий |
| 11 |
[GO] |
2022―Aug―16 |
Spontaneous Muscle Hematoma in Patient with COVID-19: Case Report |
Т.И. Каленчиц, С.Л. Кабак, С.В. Примак, Л.Г. Цедрик |
| 12 |
[GO] |
2022―Apr―27 |
Manifestation of Transient LONG QT Syndrome Caused by COVID-19. Case Report |
С.М. Комиссарова, Е.С. Ребеко, Н.М. Ринейская, Н.Н. Чакова, Т.В. Долматович, С.С. Ниязова |
| 13 |
[GO] |
2022―Apr―27 |
Viral Myocarditis in the Conditions of COVID-19 Pandemic |
С.Г. Суджаева |
| 14 |
[GO] |
2022―Mar―30 |
Gender Features of Renin-Angiotensin-Aldosterone System in the Light of the Pandemic COVID-19 |
О.С. Павлова |
| 15 |
[GO] |
2022―Mar―30 |
Pulmonary Thromboembolism and COVID-19: Place for Anticoagulant Therapy |
Е.Л. Трисветова |
| 16 |
[GO] |
2022―Mar―30 |
Myocardial Injury and Coronavirus Disease: What we Know and What are the Prospects |
О.А. Суджаева |
| 17 |
[GO] |
2022―Mar―11 |
Prevention and Management of COVID-19-Associated Venous Thromboembolism |
В.Я. Хрыщанович |
| 18 |
[GO] |
2022―Feb―11 |
Cardiovascular Events in Patients with Novel Coronavirus Infection COVID-19 |
А.А. Плешко, Е.Б. Петрова, Е.А. Григоренко, Н.П. Митьковская |
| 19 |
[GO] |
2022―Feb―11 |
International Practical Guidelines for Antithrombotic Therapy in Coronavirus Disease 2019 (COVID-19) |
В.Я. Хрыщанович, Н.Я. Скобелева, Е.В. Нелипович |
| 20 |
[GO] |
2022―Feb―11 |
Cerebral Venous Thrombosis in a COVID-19 Patient: Case Report |
Т.И. Каленчиц, С.Л. Кабак, Д.М. Гордионок |
| 21 |
[GO] |
2022―Feb―11 |
Efficacy and Safety of Preventive Anticoagulation in Patients with COVID-19-Pneumonia |
Д.П. Саливончик, И.О. Стома, Е.А. Доценко, О.А. Иванцов, Л.А. Лемешков, А.Г. Лисицын |
| 22 |
[GO] |
2022―Feb―04 |
Features of Clinical Manifestations of Coronavirus Infection CОVID-19 in Patients with Cardiovascular Diseases Who Hospitalized in Infectious Hospital |
А.Р. Тяпаева, О.Н. Семенова, Ю.В. Булаева, Е.А. Наумова |
